|
Demographic data |
|||
| Group A (ARF) |
Group B (non-ARF) |
P |
|
|
|
|||
| Number of patients |
8 |
17 |
- |
| Age (years; median [range]) |
69 (64–77) |
65 (30–86) |
NS |
| Sex (male:female) |
6:2 |
12:5 |
NS |
| ICU stay (days; median [range]) |
9 (5–22) |
6 (3–30) |
NS |
| Admission APACHE II (median [range]) |
22.5 (12–33) |
15 (6–26) |
0.01 |
| ICU mortality (n [%]) |
5 (63) |
3 (18) |
0.035 |
| Hospital mortality (n [%]) |
5 (63) |
5 (29) |
NS |
| Patients transfused (n [%]) |
6 (75) |
5 (29) |
0.043 |
| Total venesection (ml/day) |
59 ± 5 |
57 ± 9 |
NS |
| Study venesection (ml/day) |
14 ± 1 |
15 ± 2 |
NS |
| CAVHD filter blood loss (ml/day; n = 4) |
67 ± 53 |
- |
- |
| Admission serum creatinine(μmol/l; median [range]) |
366 (78–836) |
98 (54–230) < 0.001 |
|
|
Values are expressed as mean ± SD unless indicated otherwise. APACHE, Acute Physiology and Chronic Health Evaluation; ARF, acute renal failure; CAVHD, continuous arteriovenous haemodiafiltration; ICU, intensive care unit. | |||
Elliot et al. Critical Care 2003 7:R35 doi:10.1186/cc2185 |
|||